hotspot -WSS

hotspot

author：fashion 2025-09-27 09:55:20 - browse：1549

Illustration of a hospital bed with a spotlight above and money below. -- health tech coverage from STAT — Adobe

General Catalyst’s plan to take over a hospital in the coming months could be the first of many such deals, driven by financially strained hospitals looking for saviors, and venture capitalists convinced that they have the technology solutions for fixing the health care sector’s vexing problems.

The venture firm announced plans in October to acquire a health system and then use it as a proving ground for technology that its portfolio companies sell, including generative artificial intelligence-powered solutions applied to health care problems. The move — a result of industry-wide frustration with health systems’ risk aversion and hesitation to adopt new technology — also comes at a time when health tech startups that raised millions of venture dollars during the pandemic’s early stages are now scrambling to find customers.

Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program. “Hospitals are in a very tough spot,” he said, adding, “There may be hospitals that think, ‘Oh, great, someone wants to buy us.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Brain injuries and the importance of a second opinion

leisure time

WSS

Stories you might have missed in 2023: health, science, medicine

Explaining an after

What is microchimerism and how does it affect maternal health?

The health care issue Democrats can’t solve: hospital reform

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Explaining an after

focus

hotspot

explore

Activists slam private health insurers over coverage restrictions

A preacher's new calling: Diversifying neuroscience research

Drug repurposing or repositioning? The language matters

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Peter Hotez and the public health issue of online harassment

Live blog: Hearing on CRISPR

Affirmative action in medical school literally saved lives

JPM pitch from hospitals? Revenue streams outside of patient care

Trump demands the U.S. pay no more for drugs than other countries … again

Merck to acquire Harpoon Therapeutics for $680 million

hotspot

Boston Scientific acquires urology company Axonics for $3.7 billion

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

All of Us, NIH's precision medicine initiative, gets a big boost

Key Senate panel to consider PBM, drug pricing reform package

Allen Institute goes after foundational questions, CEO Costa says

Life science postdocs should get big pay hike, NIH panel says

explore

leisure time

explore

knowledge